Lv12
10 积分 2025-02-20 加入
Progressing advanced therapies for inflammatory bowel disease: Current status including dual biologic therapy and discontinuation of biologics
11小时前
已完结
Combining Anti-TNF-α and Vedolizumab in the Treatment of Inflammatory Bowel Disease: A Case Series
1天前
已完结
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial
1天前
已完结
The future of drug development for inflammatory bowel disease: the need to ACT (advanced combination treatment)
1天前
已完结
A practical guide to combination advanced therapy in inflammatory bowel disease
1天前
已完结
皖公网安备34019202002308
